Mazurek M, Białowąs E, Dybała E, Cuber I, Aghadi A. Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Educ Health Sport [Internet]. 2023 Feb. 20 [cited 2024 Sep. 12];13(4):123-31. Available from: https://apcz.umk.pl/JEHS/article/view/42431